MedPath
FDA Approval

piperacillin and tazobactam

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
July 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Piperacillin(2 g in 10 mL)
Tazobactam(0.25 g in 10 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Steriscience Pte. Limited

659844097

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Steriscience Specialties Private Limited

Steriscience Specialties Private Limited

Steriscience Pte. Limited

650391548

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

piperacillin and tazobactam

Product Details

NDC Product Code
82449-500
Application Number
ANDA065458
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
July 5, 2023
Code: M98T69Q7HPClass: ACTIMQuantity: 2 g in 10 mL
Code: UXA545ABTTClass: ACTIMQuantity: 0.25 g in 10 mL

piperacillin and tazobactam

Product Details

NDC Product Code
82449-502
Application Number
ANDA065458
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
July 5, 2023
Code: M98T69Q7HPClass: ACTIMQuantity: 4 g in 20 mL
Code: UXA545ABTTClass: ACTIMQuantity: 0.5 g in 20 mL

piperacillin and tazobactam

Product Details

NDC Product Code
82449-501
Application Number
ANDA065458
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
July 5, 2023
Code: M98T69Q7HPClass: ACTIMQuantity: 3 g in 15 mL
Code: UXA545ABTTClass: ACTIMQuantity: 0.375 g in 15 mL
© Copyright 2025. All Rights Reserved by MedPath